Treatment patterns, health care resource use and outcomes in metastatic triple-negative breast cancer in Germany: retrospective chart review study (OBTAIN)-Reference-Cited by-同舟云学术

Treatment patterns, health care resource use and outcomes in metastatic triple-negative breast cancer in Germany: retrospective chart review study (OBTAIN)

Published:2019-04-04 Issue:8 Volume:35 Page:1405-1414
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Schilling Jörg¹,Busch Steffi²,Heinrich Georg³,Heinig Karin⁴,Martin Kurbacher Christian⁵,Klare Peter⁶,Pöllinger Bernadette⁷

Affiliation:

1. Praxis, Berlin, Germany;

2. Praxis, Mühlhausen, Germany;

3. Praxis, Fürstenwalde, Germany;

4. MVZ Poliklinik Spremberg GmbH, Spremberg, Germany;

5. Medizinisches Zentrum, Bonn, Germany;

6. Praxisklinik Krebsheilkunde für Frauen/Brustzentrum, Berlin, Germany;

7. MSD Sharp & Dohme GmbH, Haar, Germany

Funder

MSD Sharp & Dohme GmbH, Haar, Germany

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1595551

Reference32 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Triple-Negative Breast Cancer

3. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

4. Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients

5. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer;Cancers;2024-03-07

2. Treatment patterns and healthcare resource utilization for triple negative breast cancer in the Brazilian private healthcare system: a database study;Scientific Reports;2023-09-22

3. Efficacy and Safety of Third-Line Apatinib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer Patients: A Multicenter, Retrospective, Cohort Study;The Tohoku Journal of Experimental Medicine;2023

4. SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients;Endocrine Oncology;2022-03-01

5. Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer;Scientific Reports;2022-01-14